This content is in French.
LITT vs. Surgery: The Revolution in Temporal Epilepsy Treatments?
12 février 2025
#Epilepsy #Surgery #LITT #Neurology #Neurosurgery
Mesial temporal lobe epilepsy (mTLE) is the most common form of drug-resistant focal epilepsy, affecting approximately one-third of epilepsy patients. This condition is characterized by recurrent seizures that do not respond to standard antiepileptic treatments, significantly impacting patients' quality of life.
The standard treatment for drug-resistant cases remains anterior temporal lobectomy (ATL), a surgical procedure that removes the brain region responsible for seizures. This approach has demonstrated high efficacy, with a significant rate of seizure freedom. However, it is associated with post-operative risks, including neurocognitive impairments, memory deficits, and risks of infections or hemorrhages. Additionally, not all patients are eligible for this surgery due to the location of epileptic foci or the presence of comorbidities.
Mesial temporal lobe epilepsy (mTLE) is the most common form of drug-resistant focal epilepsy, affecting approximately one-third of epilepsy patients. This condition is characterized by recurrent seizures that do not respond to standard antiepileptic treatments, significantly impacting patients' quality of life.
The standard treatment for drug-resistant cases remains anterior temporal lobectomy (ATL), a surgical procedure that removes the brain region responsible for seizures. This approach has demonstrated high efficacy, with a significant rate of seizure freedom. However, it is associated with post-operative risks, including neurocognitive impairments, memory deficits, and risks of infections or hemorrhages. Additionally, not all patients are eligible for this surgery due to the location of epileptic foci or the presence of comorbidities.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Mohsen, Y., et al. (2025). Efficacy and safety of laser interstitial thermal therapy vs radiofrequency ablation and stereotactic radiosurgery in the treatment of intractable mesial temporal lobe epilepsy... Neurosurgical review, 48(1), 71
View the source
